Skip to main content

Table 2 Lymphocyte subset count distribution in both training- and testing-group

From: A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients

Cellular type

Training-group

Testing-group

 

CKD(n = 9)

HD(n = 17)

p.value

CKD(n = 11)

HD(n = 13)

p.value

Ref

Percent of Total CD3 + (T cells)

75.06 ± 10.52

75.65 ± 8.23

0.87

70.05 ± 8.38

74.80 ± 7.68

0.16

66-84

Percent of CD3+/CD4 + (Helper T cells)

51.34 ± 8.77

47.12 ± 12.18

0.36

41.46 ± 8.96

46.48 ± 8.69

0.17

43-55

Percent of CD3+/CD8+ (Supressor T cells)

22.47 ± 8.35

27.14 ± 9.62

0.23

25.94 ± 7.18

27.11 ± 8.44

0.72

20-32

Percent of CD3-/CD16 + CD56+ (NK cells)

17.49 ± 8.07

17.21 ± 8.53

0.93

21.59 ± 8.59

17.20 ± 7.33

0.19

4-10

Percent of CD3-/CD19+ (B cells)

7.33 ± 7.35

7.21 ± 3.45

0.28

8.45 ± 4.27

7.54 ± 2.64

0.52

6-12

CD4: CD8 Ratio

2.58 ± 1.02

2.08 ± 1.14

0.94

1.77 ± 0.70

2.00 ± 1/13

0.55

2-3

  1. Values are expressed as mean±SD. P-values calculated by T-Test.